Evidence review · Published July 22, 2026 · Sources checked July 22, 2026

NAD+ research overview

Nicotinamide adenine dinucleotide (NAD+) is a central redox cofactor and substrate for multiple enzyme families. It is a nucleotide-derived metabolite, not a peptide.

Evidence boundary: published research does not establish the identity or performance of a separately supplied batch. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.

What is NAD+?

Cellular research has measured distinct cytosolic, nuclear, and mitochondrial NAD pools and identified mammalian mitochondrial transport mechanisms.

Research category

Metabolic & energy research

Study models represented

Genetically encoded biosensors, cultured cells, and mitochondrial transport studies

Names in the literature

Nicotinamide adenine dinucleotide; oxidized NAD

Primary boundary

Intracellular pathway findings do not establish effects of a supplied formulation.

What does the selected evidence support?

Core biochemical importance does not establish that changing extracellular NAD+ produces a particular organism-level or clinical outcome.

Primary sources

1. Cambronne et al., Science (2016) — Genetically encoded biosensor measurements of subcellular NAD pools. DOI: 10.1126/science.aad5168
2. Davila et al., eLife (2018) — Identification and characterization of mammalian mitochondrial NAD transport. DOI: 10.7554/eLife.33246

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Review NAD+ product specifications · Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.